French Institute Of Health And Medical Research

The Japanese company behind an experimental Ebola treatment says it offers new hope for thousands of people infected with the deadly virus in west Africa, but acknowledged it is "not a miracle drug".

Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed on Monday that it was somewhat effective at saving lives if given early in the illness, but not later.

The Japanese company behind an experimental Ebola treatment says it offers new hope for thousands of people infected with the deadly virus in west Africa, but acknowledged it is "not a miracle drug".

Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed on Monday that it was somewhat effective at saving lives if given early in the illness, but not later.